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Imprinted genes are regulated according to parental
origin and can influence embryonic growth andmeta-
bolism and confer disease susceptibility. Here, we
designed sensitive allele-specific reporters to non-
invasively monitor imprinted Cdkn1c expression in
mice and showed that expression was modulated
by environmental factors encountered in utero. Acute
exposure to chromatin-modifying drugs resulted in
de-repression of paternally inherited (silent) Cdkn1c
alleles in embryos that was temporary and resolved
after birth. In contrast, deprivation ofmaternal dietary
protein in utero provoked permanent de-repression
of imprinted Cdkn1c expression that was sustained
into adulthood and occurred through a folate-depen-
dent mechanism of DNA methylation loss. Given the
function of imprinted genes in regulating behavior
and metabolic processes in adults, these results
establish imprinting deregulation as a crediblemech-
anism linking early-life adversity to later-life out-
comes. Furthermore, Cdkn1c-luciferase mice offer
non-invasive tools to identify factors that disrupt
epigenetic processes and strategies to limit their
long-term impact.INTRODUCTION
Epigenetics is the study of heritable changes in gene expression
that arise from non-genetic influences. Genomic imprinting is an
epigenetic process found in eutherian and metatherian mam-
mals that results in parent-of-origin-specific allelic expression
(John and Surani, 2000). A relatively small subset of genes within
the mammalian genome (0.4%) is imprinted (Surani et al., 1984;
McGrath and Solter, 1984), and these showmono-allelic expres-1090 Cell Reports 18, 1090–1099, January 31, 2017 ª 2017 The Auth
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maternal (e.g., Cdkn1c and Ube3a) or the paternal allele (e.g.,
Dlk1 andNnat; Monk et al., 2006). Imprinted expression is initially
determined by differential DNA methylation that is established in
the germline (Surani, 1998). Although the rationale for genomic
imprinting remains uncertain, the critical role of imprinted genes
in embryonic growth, placental development, and neurogenesis
(Cleaton et al., 2014) suggests that imprinting may serve to bal-
ance the selective pressures between parental genomes and
control in utero offspring demand (Wolf and Hager, 2006; Day
and Bonduriansky, 2004; Haig, 2004). Imprinted genes encode
proteins that have a wide range of roles in nutrient transport,
signaling, cell-cycle control, protein synthesis and degrada-
tion, and ion channel function. Their impact extends into post-
natal life with key roles in the regulation of both metabolic and
neuronal processes. Alterations at imprinted gene loci in humans
are associated with rare disorders, such as Beckwith-Wiede-
mann syndrome (Lam et al., 1999), and also more common
pathological conditions, including mental disability, impaired
neuro-behavioral function, diabetes, obesity, muscle hypertro-
phy, and also with cancer (Radford et al., 2011).
Despite their importance, imprinted genes are particularly
challenging to study. This in part reflects experimental difficulties
that are common to mono-allelic genes, in that gene deletion
experiments show all or nothing effects, whereas alterations
in gene dosage can result in complex phenotypes in which
isolating genetic and epigenetic traits is problematic (Cleaton
et al., 2014; John, 2010). In addition, imprinted genes are
often clustered within genomic domains in which regulation is
achieved through multiple levels of epigenetic control, including
DNA methylation, non-coding RNAs, and modified histones
(Bartolomei and Ferguson-Smith, 2011). Finally, studies to
assess the impact of chromatin-modifying drugs or environ-
mental stress on imprinted gene expression require the maternal
and paternal alleles to be discriminated on the basis of heterozy-
gous SNPs or have used LacZ-based targeting of endogenous
alleles (John, 2010). Whereas such approaches provide valuable
generic tools to examine imprint dynamics through developmentors.
commons.org/licenses/by/4.0/).
Figure 1. Visualizing Cdkn1c Gene Expression In Vivo Using Bioluminescence
(A) Scheme of alternative knockin (KI) strategies used to generateCdkn1c-FLucLacZ andCdkn1c-FLuc embryonic stem cells (ESCs) and reporter mouse lines, in
which sequences coding for the T2A peptide, the open reading frame of FLuc, a second T2A peptide, and the open reading frame of LacZ were inserted between
the last amino acid and the translation termination codon in exon 3 (.KRLREGRG.; Cdkn1c-FLucLacZ) or IRES elements and the open reading frame of FLuc
was inserted into a unique HindIII in the 30 UTR (Cdkn1c-FLuc).
(legend continued on next page)
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and in response to stress, the invasive nature of the allelic
readout means that it is not feasible to longitudinally monitor
imprinted gene expression in different individuals throughout
their life course. Models using fluorescence-based reporters
have provided non-invasive readouts at whole-body and sin-
gle-cell resolution (Jones et al., 2011; Swanzey and Stadtfeld,
2016), but tissue depth and sensitivity constraints may limit their
general applicability. To provide new tools for investigating the
consequences of early-life adversity, we generated a series of
knockin embryonic stem cells (ESCs) and mouse lines in which
firefly luciferase reports endogenous imprinted gene expression,
and non-invasive bioluminescent imaging provides a means of
monitoring expression longitudinally in vivo.
Cdkn1c is amaternally expressed imprintedgene that lieswithin
the imprinting cluster 2 (IC2) on mouse chromosome 7 and is
imprinted in both mice and humans (Hatada and Mukai, 1995;
Hatada et al., 1996). The gene encodes a cyclin-dependent kinase
inhibitor that is transiently expressed during embryogenesis in
cells exiting proliferation (Lee et al., 1995; Matsuoka et al., 1995)
and is particularly abundant within neural and skeleto-muscular
tissue around mid-gestation (Westbury et al., 2001). Cdkn1c has
an important role in regulating fetal growth and placental develop-
ment (Andrews et al., 2007; Takahashi et al., 2000; Tunster et al.,
2011) aswell as lineage-specific roles, including in brown adipose
tissue (Van De Pette et al., 2016), skeletal muscle (Osborn et al.,
2011), and in adult quiescent stem cells (Zacharek et al., 2011;
Matsumoto et al., 2011; Joseph et al., 2009). Cdkn1c lies within
a complex imprinted domain regulated by an imprinting center
that acquires DNA methylation in the maternal germline (gametic
DMR; KvDMR1; John and Lefebvre, 2011; Hatada and Mukai,
1995; Hatada et al., 1996; Mohammad et al., 2012). This differen-
tially methylated region spans the promoter of the paternally ex-
pressed long non-coding RNA Kcnq1ot1 required for continuous
domain-wide imprinting. The Cdkn1c promoter and gene body
are also directly DNAmethylated on the paternal allele post-fertil-
ization, after allelic silencing has been established (somatic DMR;
Cdkn1c-sDMR [somatic differentially methylated region]; Bhogal
etal., 2004).Given theprofoundeffectofmodestdosagealteration
of this gene on post-natal metabolic and behavioral processes
(Andrews et al., 2007; Van De Pette et al., 2016; McNamara(B) Low-level bioluminescence (blue-green) inCdkn1c-FLucLacZ and Cdkn1c-FLu
not in clones with a paternal insertion (KIpat) or in wild-type ESCs (wt) (scale bar
(C) TotalCdkn1c expression (left), determined by RT-PCR, was increased in ESC c
of embryoid body differentiation. Luciferase expression (right), determined by R
b-actin and expressed as the mean ± SE.
(D) Bioluminescent imaging of representative P28 female Cdkn1c-FLucLacZ mic
negligible signals detectable upon paternal inheritance (KIpat) or in wild-type mice
the internal organs.
(E) Bioluminescence detected in pregnancies with maternal inheritance of Cdkn1
than twice background). Lower panels show bioluminescence imaging of dissecte
embryos and placental tissue and quantified (flux). All Cdkn1c-FLucLacZ embryo
(F) TotalCdkn1c gene expression in embryos (E11.5) was determined byRT-PCR,
was transmitted maternally (KImat) or paternally (KIpat; left). Luciferase (black) a
Samples were normalized to b-actin and expressed as the mean ± SE.
(G) Scheme of the mouse IC2 imprinting domain, showing the two DMRs that r
position of bi-allelic (white), maternally expressed (dark gray), and paternally expre
and Cdkn1c sDMR is similar in KImat and wt embryos at E11.5 (closed circles
methylated strands).
1092 Cell Reports 18, 1090–1099, January 31, 2017et al., 2016), it provides an ideal candidate to study using sensitive
allele-specific reporters.
RESULTS
Generating Luciferase-Based Allelic Reporters for
Mouse Cdkn1c
Mouse ESC lines were generated in which firefly luciferase (FLuc)
alone, or in combination with b-galactosidase (FLucLacZ), was
knocked into the endogenous Cdkn1c locus (Figures S1A and
1A, respectively). In some of the resulting targeted clones, low-
level bioluminescence was detected after adding the luciferase
substrate D-luciferin, consistent with insertion of luciferase into
the maternal allele in selected clones (Figure 1B, blue). Upon
differentiation, we observed increased expression of Cdkn1c
(Figures 1C, left, and S1B, left), as anticipated from previous
studies (Wood et al., 2010). In clones with a presumed maternal
insertion, increased Cdkn1c expression was coupled to a corre-
sponding increase in luciferase expression (Figures 1C and S1B).
In clones with a presumed paternal insertion (KIpat), increased
levels ofCdkn1c expression were not accompanied by luciferase
expression (Figures 1C and S1B), consistent with maintenance
of the silent imprint.
Mice were generated from targeted ESCs to test whether
bioluminescence was observed in offspring (Figures 1D and
S1C) and to verify that this activity was transmitted in the appro-
priate parent-of-origin manner. Maternal transmission of the
FLucLacZ transgene resulted in bioluminescent signal in the
skin and internal organs of transgenic offspring (blue signal;
KImat) at 4 weeks of age, with no signal evident in offspring
after paternal inheritance (KIpat) or in non-transgenic (wild-type
[WT]) controls (Figure 1D). Strikingly, pregnant females carrying
embryonic day 11.5 (E11.5) Cdkn1c-FLucLacZ KImat embryos
(14/14), but not KIpat embryos (0/10), showed a strong biolumi-
nescent signal in the abdominal region (Figure 1E, upper).
On dissection, transgenic embryos and placenta carrying the
maternal targeted allele appropriately expressed luciferase,
whereas those carrying the paternal targeted allele show no
bioluminescence (Figure 1E, lower). Similar results were ob-
tained with Cdkn1c-FLuc mice (Figure S1C).c ESCs was detected in clones with a presumedmaternal insertion (KImat), but
represents levels of bioluminescence).
lones with either a KImat (dashed line) or a KIpat (solid line) insertion over 21 days
T-PCR, was detected uniquely in KImat clones. Samples were normalized to
e. Luciferase activity was observed in Cdkn1c-FLucLacZ KImat, with very low/
(wt). Strongest signal was evident in the skin, with low level signal detected in
c-FLucLacZ (KImat, left) in utero, but not paternal inheritance (KIpat, right; less
d E11.5 embryos, where luciferase activity was seen in head and back of KImat
s imaged showed predicted parent-of-origin-specific bioluminescent activity.
and levels were similar in samples fromwild-type andwhereCdkn1c-FLucLacZ
nd Cdkn1c-Luciferase (gray) transcripts were detected uniquely from KImat.
egulate Cdkn1c imprinted expression (KvDMR1 and Cdkn1c sDMR) and the
ssed (light gray) genes. Bisulfite analysis showing DNAmethylation atKvDMR1
, methylated; open circles, un-methylated; where number indicates fully un-
Figure 2. Correct Imprint Resetting of
Cdkn1c-FLucLacZ across Generations
(A) Diagram showing predicted expression and
inheritance of a maternally expressed imprinted
gene (such as Cdkn1c) or transgene (Cdkn1c-
FLucLacZ) in reciprocal crosses across three
generations. Wild-type mice are shown in white,
expression through maternal inheritance is shown
in blue, and inheritance of a silent imprint (Cdkn1c-
FLucLacZ; KIpat) is indicated in gray.
(B) Experimental evidence of imprint resetting;
bioluminescent imaging of adult F2 mice, Cdkn1c-
FLucLacZ KIpat females (left box), and KImat males
(right box), showing predicted parent-of-origin-
specific luciferase activity (blue). Highlighted
animals were then used to generate F3 (as out-
lined in A).
(C) Bioluminescent image of E14.5 embryos,
generated from the indicated transgenic parents;
signal was detected upon maternal inheritance
of luciferase in embryos (upper panel) and in
placental tissue (lower panel; left), which had been
silent in the previous generation. Conversely,
paternal inheritance of the previously active lucif-
erase was sufficient to silence the previously
active allele (right).Staining of E11.5 Cdkn1c-FLucLacZ KImat embryos for LacZ
(Figure S1D) confirmed spatially appropriate expression in the
hindbrain, spine, and developing cartilage, consistent with the
published distribution of Cdkn1c (Westbury et al., 2001). This
was further verified by 3D imaging using optical projection tomog-
raphy (OPT) of cleared embryos (Figure S1D, lower; Movie S1),
combined with photoacoustic tomography (Figure S1E). Impor-
tantly, no staining was detected in KIpat embryos by this sensitive
approach, confirming global repression of the paternal allele.
Consistent with this, luciferase mRNA was only detectable after
maternal inheritance (Figure 1F) alongside wild-type levels of the
Cdkn1c transcript. Amplification with a primer set that spanned
Cdkn1c exon 3 and luciferase exon 1 confirmed linked expression
of luciferase and endogenous Cdkn1c transcripts (Figure 1F).
Bisulfite analysis of the two differentiallymethylated regions asso-
ciated with Cdkn1c imprinting (Bhogal et al., 2004; Mancini-Di-
nardo et al., 2006) showed normal DNA methylation patterns in
heads of Cdkn1c-FLucLacZ KImat embryos (Figure 1G). Collec-Cell Repotively, these data indicate that luciferase
accurately reports Cdkn1c expression
without impairing the methylation or regu-
lation of the endogenous locus.
Imprinted Cdkn1c-FlucLacZ
Expression Is Appropriately Reset
through the Germline
Epigenetic marks that establish and
maintain imprinting are normally erased
and reset in the germline so that
allelic expression is correctly maintained
in subsequent generations (Bartolomei
and Ferguson-Smith, 2011). To checkwhether erasure and resetting of imprints occurred normally
in the luciferase-targeted mice, we tracked bioluminescence
(blue) among reciprocal genetic crosses of Cdkn1c-FLucLacZ
(gray) and wild-type mice (white) across generations (Figure 2A;
F1, F2, and F3). Tracing bioluminescence activity across three
generations revealed epigenetic inheritance as predicted (Fig-
ures 2B and 2C), in which allelic silencing of Cdkn1c-FLucLacZ
was reversed through maternal transmission and re-established
through paternal transmission. The ability to image Cdkn1c
expression longitudinally in vivo through successive generations
suggested that these reporter mice might be useful and robust
models to screen for factors and environmental stresses that
could interfere with imprinting. Importantly, as female mice in-
heriting Cdkn1c-FLucLacZ paternally (KIpat; left box, Figure 2B)
were devoid of luciferase signal, these animals offered an
optimal setting (minimal background) to detect bioluminescence
signals in utero from KImat embryos and placental tissue (Figures
1E, left, and 2C).rts 18, 1090–1099, January 31, 2017 1093
Figure 3. Silencing of Paternal Cdkn1c-FLucLacZ Is Transiently Released by In Utero Exposure to Epigenetic Drugs
(A) Embryos carrying silent (paternally inherited)Cdkn1c-FLucLacZwere generated bymating wild-type (wt) females with homozygousCdkn1c-FLucLacZmales.
Pregnant females were treated with trichostatin A (TSA) or 50 azacytidine (50Aza) alone or together at the times indicated. Offspring were imaged at E14.5, at birth
(P1), and at 4 weeks of age (P28).
(legend continued on next page)
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Chromatin-Modifying Drugs Transiently Disrupt
Paternal Silencing of Cdkn1c In Utero
50azacytidine (50Aza) disrupts DNA methylation in cells by inhib-
iting DNMT1 activity, thereby preventing the incorporation of
5-methylcytosine into hemi-methylated DNA strands at S phase.
In dividing cells in culture, 50Aza treatment has been shown to
reduce DNA methylation at the Cdkn1c promoter (Flotho et al.,
2009). Trichostatin A (TSA) inhibits histone deacetylase activity
and has been shown to deplete repressive histone marks at
the Cdkn1c promoter (Yang et al., 2009). We reasoned that
drugs that alter chromatin, such as 50Aza and TSA, might be
effective at disrupting Cdkn1c expression when epigenetic
marks are consolidated (Bhogal et al., 2004; Umlauf et al.,
2004). To examine this possibility, wild-type female mice were
crossed with homozygous Cdkn1c-FLucLacZ (KI/KI) males to
produce heterozygous offspring in which the Cdkn1c-FLucLacZ
imprint was repressed. The pregnant females were then treated
with drugs at E12.5–E13.5, and bioluminescence was evaluated
at E14.5, at birth (P1), and at 4 weeks of age (postnatal day 28
[P28]; Figure 3A). Bioluminescence was detected in utero at
E14.5 with strongest signal seen following combined drug treat-
ment (Combi) (Figure 3B). Control vehicle-treated KIpat embryos
were consistently negative throughout these studies. For 50Aza-
(3/9) and TSA-treated (4/9) pregnancies, bioluminescence was
not detected in all the transgenic embryos, whereas all the trans-
genic embryos (7/7) displayed increased luciferase activity upon
combination treatment (Figure 3C). These animals showed a cor-
responding decrease in DNA methylation across the Cdkn1c
somatic DMR at E14.5 as compared with controls (Figure 3D).
We noticed that the levels of bioluminescence were generally
lower than in age-matched Cdkn1c-FLucLacZ KImat embryos,
consistent with partial de-repression of the paternal allele.
Furthermore, de-repression appeared transient andwas variable
among combination drug-treated animals, as shown in pups
imaged at birth (P1; Figure 3E). Four weeks after birth (P28),
bioluminescence signal was no longer evident in drug-treated
KIpat animals (Figure 3F), and DNA methylation in the brain was
similar in vehicle- and Combi-treated Cdkn1c-FLucLacZ KIpat
mice (Figure 3G). Taken together, these data show that conven-
tional chromatin-modifying drugs alone or in combination are
capable of relieving imprinted Cdkn1c-FLucLacZ repression in
developing embryos.
Dietary Protein Restriction In Utero Provokes De-
repression of Paternal Cdkn1c into Adulthood
Cdkn1c has previously been proposed to be sensitive to in utero
dietary protein restriction (Vucetic et al., 2010). In particular, mice
that were fed a low-protein diet through pregnancy (as a surro-(B) Low-level bioluminescence was occasionally detected in 50Aza- and TSA-a
detected in combination-treated (Combi) embryos in utero (left) or individually di
(C) Cdkn1c-FLucLacZ-derived bioluminescent activity was consistently elevated
(D) Bisulfite analysis of DNA methylation at the KvDMR1 and Cdkn1c sDMR in the
embryos exposed to combination drug treatment versus controls (closed circles
(E) Variable increases in luciferase activity (blue, flux) characterize combination-dr
in vehicle-treated controls (left).
(F) Luciferase activity was no longer detected in Cdkn1c-FLucLacZ KIpat mice at
(G) Bisulfite analysis of DNA methylation at the KvDMR1 and Cdkn1c sDMR in
methylation is restored by adulthood to normal levels (closed circles, methylatedgate for early-life adversity) produced offspring with elevated
levels of Cdkn1c in the midbrain associated with DNA hypo-
methylation at the promoter. To examine whether exposure to
low-protein diet in utero provokes de-repression of the silent
paternal Cdkn1c-FLucLacZ, we crossed wild-type female mice
with heterozygous Cdkn1c-FLucLacZ (WT/KI) males (Figure 4A,
schematic). Pregnant mice were fed calorie-balanced, low-pro-
tein diet (LP) from the detection of vaginal plugs until birth. All
newborn offspring were maintained thereafter on a normal (unre-
stricted) diet. This window of exposure ensures that the influence
of LP diet is restricted to a specific period of development.
Although bioluminescence signal was not detected at E11.5
(Figure S2), by E14.5, all Cdkn1c-FLucLacZ KIpat embryos ex-
pressed luciferase following maternal exposure to low-protein
diet (exemplified in Figure 4A,middle right). Signal wasmost pro-
nounced in the head, and luciferase re-expression among KIpat
embryos was prominent in the midbrain region (Figure S3).
De-repression was sustained in mice imaged subsequently at
4 weeks of age (Figure 4A, lower right) and throughout adult-
hood, despite no longer being exposed to a restricted diet.
These data establish that in utero exposure to a low-protein
diet results in permanent de-repression of the normally silent
paternal allele.
To further explore the mechanism underlying Cdkn1c re-ex-
pression, we compared DNA methylation in the brain at E11.5,
E14.5, and in adults at 4 weeks of age (Figure 4B). Appropriate
DNA methylation at the somatic DMR was evident at E11.5,
when no luciferase activity was detected (Figure S2), but
this was progressively eroded in animals exposed to LP diet dur-
ing gestation (Figure 4B). These data show that, under these
conditions, the somatic DMR is established correctly, but not
maintained, suggesting that dietary protein may be required
to sustain DNA methylation at the paternal allele. In contrast,
DNA methylation at KvDMR1 was unaffected by LP diet (Fig-
ure 4B), consistent with previous reports (Ivanova et al., 2012).
Rescue of Dietary-Induced Loss of Paternal Cdkn1c
Silencing by Folate Supplementation
As dietary protein is known to be an important source of methyl
donors required for DNA methylation, we hypothesized that a
paucity of methyl donorsmight contribute to the failure to sustain
repression of Cdkn1cpat alleles in vivo. To test this, we repeated
the dietary experiments using the low-protein diet with increased
folate supplementation as a source of methyl donors. This had a
dramatic effect, reducing paternal Cdkn1c-FLucLacZ biolumi-
nescence to background levels in embryos (Figure 4C, left) and
in resulting adults (Figure 4C, right). We also found that, following
folate supplementation, methylation of Cdkn1c somatic DMRlone treated pregnancies, whereas stronger and consistent signal (blue) was
ssected embryos (right) in the head and back.
in E14.5 embryos exposed to combined drug treatment.
brain of E14.5 Cdkn1c-FLucLacZ KIpat embryos shows reduced methylation in
, methylated; open circles, un-methylated).
ug-treatedCdkn1c-FLucLacZKIpat animals at P1 (right), with no signal detected
P28 that had been exposed to combination drug treatment in utero.
the brain of P28 Cdkn1c-FLucLacZ KIpat mice shows that previously ablated
; open circles, un-methylated).
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Figure 4. Stable Silencing of Paternally Inherited Cdkn1c-FLucLacZ during Life Course Depends upon the Availability of Methyl Donors
In Utero
(A) Offspring with a silent (paternally inherited) Cdkn1c-FLucLacZ were generated by mating wild-type (wt) females with heterozygous Cdkn1c-FLucLacZ
males. Upon detection of a vaginal plug, a group of pregnant females were switched to a calorie-matched but low-protein (LP) diet for the duration of their
pregnancy, with mothers and litters returning to a normal diet after birth. Pregnancies were imaged/examined at the times indicated (E11.5, E14.5, and P28). No
(legend continued on next page)
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was indistinguishable from normal controls (Figures 4B and 4D).
De-repression and restoration of Cdkn1c-FlucLacZ silencing
in response to LP and LP + folate diet, respectively, was directly
validated by allele-specific transcript analysis (Figure 4E). Thus,
although previous studies have shown Cdkn1c upregulation in
response to LP diet (Vucetic et al., 2010), our data now establish
that dietary restriction can cause loss of imprinting.
DISCUSSION
In utero development is critically dependent on imprinted gene
dose (Radford et al., 2011). This necessary control has been
shown to extend into the programming of adult metabolism
(Da Rocha et al., 2009; Charalambous et al., 2012). Here, we
show that maternal dietary restriction has a profound impact
on Cdkn1c expression in the embryo, provoking a partial loss
of imprinting that persists through adult life, even when a normal
diet is resumed. Prolonged exposure to low-protein diet during
gestation erodes DNA methylation at the Cdkn1c somatic
DMR and results in re-expression of the paternal allele. Because
deregulation is rescued by elevated folate supplementation,
methyl donor deprivation appears to be the most likely cause
of imprint erosion. Although we do not yet know whether this
reflects a specific window of vulnerability in embryonic develop-
ment or simply an increased demand engendered by prolif-
erating cells in the embryo, the observation that the gametic
KvDMR1 DMR resists DNA de-methylation supports previous
findings that gametic differentially methylated regions (gDMRs)
are relatively stable (Ivanova et al., 2012). Mechanistically,
gametic and somatic DMRs both require the maintenance of
DNA methylation by DNMT1 (Caspary et al., 1998; Bhogal
et al., 2004). However, whereas zygotic deficiency of the de
novo methylases Dnmt3a or 3b has no effect on gDMR methyl-
ation, loss of Dnmt3b results in de-methylation of Cdkn1c-
sDMR independent of KvDMR1 status (Auclair et al., 2014).
These data provide a precedent for the differential sensitivities
of the gametic and somatic DMRs and implicate Dnmt3b as a
candidate in preventing hypo-methylation at the Cdkn1c sDMR.
Imprinted genes are pivotal for regulating growth and meta-
bolism, and yet the intricacies of imprinting have remained
challenging to study. This reflects the intrinsic complexity of
imprinting control regions (ICRs) but also a paucity of markers
needed to reliably distinguish maternal from paternal alleles.
Here, we describe two independent mouse lines in which lucif-mis-expression of luciferase was observed at day E11.5 (Figure S2), irrespecti
embryos of mothers fed LP diet (upper right) and expression continued as these
(control) diet at any time.
(B) Comparative bisulfite analysis of DNAmethylation at theCdkn1c locus in the b
fed control versus LP diet during pregnancy. Cdkn1c sDMR becomes hypo-meth
(closed circles, methylated; open circles, un-methylated). Methylation at the KvD
(C) Pregnant females as in (A) were fed LP diet supplemented with increased fol
showed reduced mis-expression of Cdkn1c-FLucLacZ KIpat as compared with th
matured into adults (P28; upper right; image scales same as A).
(D) Bisulfite analysis showing DNA methylation at KvDMR1 and Cdkn1c sDMR i
Progressive hypo-methylation of the Cdkn1c sDMR was buffered against by the
(E) Total Cdkn1c gene expression in E14.5 brain was determined by RT-PCR, and
to control and LP + folate litters (p < 0.38). Luciferase (black) andCdkn1c-Lucifera
demonstrating loss of imprinting. Samples were normalized to b-actin and expreerase-based bioluminescence reports allelic Cdkn1c expres-
sion, without disruption of endogenous gene output. The value
of using this non-invasive approach is that it allows allelic
expression to be imaged in individuals throughout life course
so that epigenetic changes and their consequences can be
evaluated directly. The close correspondence of luciferase
expression in Cdkn1c-FLuc and Cdkn1c-FLucLacZ mouse lines
suggests similar approaches might also be useful in studying
allelic expression from other imprinted loci. Consistent with
this idea, we have generated a series of ESC lines that report
maternally expressed (Ube3a) or paternally expressed imprinted
genes (Dlk1, Nnat, and Igf2) and are characterizing luciferase
expression in mouse lines derived from such (Table S1). These
lines, together with the Cdkn1c-FLucLacZ and Cdkn1c-FLuc
lines described herein, provide novel genetic tools to interrogate
the epigenetic mechanisms that establish, maintain, and repro-
gram imprinted gene expression in the female and the male
germlines.
The observation that the Cdkn1c imprint is permanently dis-
rupted by altered maternal diet provides a clear link between
early-life adversity and the subsequent epigenetic mis-regula-
tion in adult life. Our results suggest that a deficiency in methyl
donor supply in utero is the most likely cause of imprint disrup-
tion, whereas limited exposure to well-characterized chro-
matin-modifying drugs in utero transiently deregulates imprint
silencing. The basis of these different epigenetic outcomes is
interesting and could reflect differences in the timing or length
of exposure, inherent differences in cell proliferation, or the
susceptibility of developing tissue to certain agents. Although
future studies will be required to discriminate these possibilities,
our ability to detect transient and permanent changes in imprint
silencing in vivo offers an exciting new opportunity to explore
the plasticity of epigenetic processes and their phenotypic
outcome. More broadly, these luciferase-based imaging models
will facilitate the rapid screening of epigenetic drugs and environ-
mental stresses relevant for drug discovery programs and for
understanding how epigenome deregulation in early life impacts
upon longer-term health.EXPERIMENTAL PROCEDURES
Animal Maintenance
Mice were handled and all in vivo studies were performed in accordance
with the United Kingdom Animals (Scientific Procedures) Act (1986), wereve of diet; however, by E14.5, luciferase activity was detected selectively in
matured into adults (lower right). No signal was detected in animals fed normal
rain ofCdkn1c-FLucLacZ KIpat animals (E11.5, E14.5, and P28) born to mothers
ylated in LP conditions in utero, and methylation is not restored subsequently
MR1 is unaltered.
ate. Bioluminescent imaging of embryos (E14.5) from mothers fed LP + folate
ose fed LP alone (A), with luciferase activity remaining low or negligible as they
n E14.5 (upper) and P28 (lower) animals born to mothers fed LP + folate diet.
increased dietary folate.
levels were elevated in samples from LP-exposed litters (p < 0.033), compared
se (gray) transcripts were detected using RT-PCR uniquely in LP brain samples,
ssed as the mean ± SE.
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approved by the Imperial College AWERB committee, and performed under a
UK Home Office project license.
Epidrug Injections
50Aza (Sigma-Aldrich) and TSA (Sigma-Aldrich) were dissolved as 0.75 mg/mL
and 0.3 mg/mL stocks in PBS and 30% ethanol, respectively. Wild-type
129S2/SvHsd dams were set up with Cdkn1c-FLucLacZ males, and upon
vaginal plug discovery, matings were separated. For 50Aza administration,
pregnant dams were injected with 5 mg/g body weight at E12.5 intraperitone-
ally (i.p.). For TSA administration, pregnant dams were injected i.p. with 1 mg/g
body weight at E12.5 and E13.5. Vehicle injections were performed with 30%
ethanol at the same time points as TSA injections. Pregnant dams and em-
bryos were imaged at E14.5; offspring were imaged at P1 and P28.
Low Protein Study
Wild-type 129S2/SvHsd dams were set up withCdkn1c-FLucLacZmales, and
upon vaginal plug discovery, matingswere separated. Females were fed either
a low-protein chow (5769; TestDiet), a calorie-matched control chow (5755;
TestDiet), or a low-protein chow with elevated folate supplement (5769 with
20 PPM Folate; TestDiet) until E11.5 or E14.5 for embryonic studies or birth
for adult studies. Pregnant dams and embryos were imaged at E14.5; offspring
were imaged at P28.
Bioluminescent Imaging
D-Luciferin (PerkinElmer) was dissolved in H20 at 30 mg/mL. For in vitro
studies, cells were grown to 90% confluence, 150 mg/mL was added to
the medium, and plates were imaged after 2 min. For in vivo studies,
mice were weighed and injected i.p. with 0.15 mg/g body weight before be-
ing anesthetized with isoflurane. Mice were imaged 10 min post-injection in
an IVIS Spectrum (PerkinElmer) under anesthesia. Images of cell plates,
adult mice, and pregnant dams were taken at field of view (FOV) C, with
binning 4 and 180 s exposure. For imaging of embryos, pregnant females
were injected with D-Luciferin at least 10 min prior to imaging. Embryos
were dissected into 24-well dishes containing PBS and placed in the IVIS
Spectrum. Images of embryos were taken at FOV A, with binning 1, focus
1 cm, and 180 s exposure. For epidrug and low protein imaging, settings
were the same, with the exception of binning 4 in embryos. No additional
D-Luciferin was added, and imaging continued for up to 35 min post-injec-
tion. Analysis of images was performed on Living Image software (Caliper
Life Sciences). For quantification of bioluminescent signal, regions of inter-
est were drawn around embryos and signal flux within the region was
calculated.
SUPPLEMENTAL INFORMATION
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